Cited by 24Growth Hormone and Insulin-like Growth FactorsHormonal and reproductive studiesHIV-related health complications and treatments

Partial growth hormone deficiency is associated with an adverse cardiovascular risk profile and increased carotid intima-medial thickness

Murray, Robert D., Wieringa, Gilbert, Lawrance, Jeremy A., Adams, Judith E., Shalet, Stephen M.·2010·Clinical Endocrinology

Abstract

OBJECTIVE: To quantify the relative prevalence of surrogate markers of vascular risk in adults with partial GH deficiency (GH insufficiency, GHI). CONTEXT: Hypopituitary adults with untreated GH deficiency (GHD) have an excess vascular mortality and demonstrate clustering of adverse vascular risk factors. The vascular risk profile of GHI adults has yet to be comprehensively studied. DESIGN: A cross-sectional case controlled study. PATIENTS: Thirty GHD adults, 24 GHI, and 30 age- and sex-matched controls. GHI adults were defined biochemically using two GH stimulation tests (peak GH 3-7 μg/l). MEASUREMENTS: Serum lipids and apolipoproteins, plasminogen activator inhibitor type-I (PAI-I), C-reactive protein (CRP), lipoprotein (a) [Lp(a)], fibrinogen, blood pressure and carotid intima-medial thickness (IMT). RESULTS: IGF-I levels of GHI adults were lower than controls (373 ± 123 vs 295 ± 104 μg/l; P < 0.001). Total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C) and triglycerides (TG) values were consistently between those of, but not significantly different from, GHD and control subjects. GHI adults showed significantly elevated PAI-I levels [80 (13-98) vs 50.5 (3-98) ng/ml; P = 0.01], although no there were differences in CRP, Lp(a), and fibrinogen levels compared with control subjects. No differences in systolic or diastolic blood pressure were shown between study groups. In parallel with the increased vascular risk profile of GH-insufficient adults, carotid IMT was significantly increased (0.503 ± 0.08 vs 0.578 ± 0.130 mm; P = 0.02). TC, LDL-C, Waist-Hip Ratio (WHR), truncal fat mass, and IMT correlated with IGF-I levels and GH status. TG, K(ITT), and PAI-I additionally correlated with GH status, but not with IGF-I levels. CONCLUSION: GHI adults are at elevated vascular risk, reflected by adverse surrogate markers and increased carotid IMT. The surrogate risk marker profile parallels GHD adults, but is less divergent from that observed in healthy individuals. No data are yet available as to whether these anomalies will be reflected in an increased vascular mortality in GHI adults.

Integrity signals

Registry

Crossref · 10.1111/j.1365-2265.2009.03754.x

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD.

    “Altered body composition, insulin resistance, hypertension, unfavorable lipid profile, endothelial dysfunction and atherosclerosis have been found in several studies on patients with long-term GHD (74,76,77,(82)(83)(84)(85)(86)(87).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Murray, R. D., Wieringa, G., Lawrance, J. A., Adams, J. E., & Shalet, S. M.
Affiliations
  • Leeds Teaching Hospitals NHS Trust (GB)
  • The Christie Hospital (GB)
  • University of Manchester (GB)
Corresponding author
Murray, Robert D.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
2009-12-18
Volume
73
Issue
4
Pages
508-515
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2063135802
Cited by
24
References
49
Citations by year
2026: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2018: 1 · 2017: 4 · 2016: 3 · 2015: 1 · 2014: 3 · 2013: 1 · 2012: 6
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Locations
  • Clinical Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
  • Health Sciences › Medicine › Emergency Medicine › HIV-related health complications and treatments
Keywords
partial growth hormone deficiency, growth hormone deficiency, cardiovascular risk, carotid intima-media thickness, vascular risk markers, insulin-like growth factor I, serum lipids, apolipoproteins, C-reactive protein, lipoprotein(a), fibrinogen, blood pressure, hypopituitarism, adults, truncal fat
MeSH terms
Adult, C-Reactive Protein, Cardiovascular Diseases, Carotid Arteries, Cross-Sectional Studies, Female, Humans, Insulin-Like Growth Factor I, Lipids, Male, Risk Factors, Case-Control Studies, Plasminogen Activator Inhibitor 1, Tunica Intima, Tunica Media, Human Growth Hormone, Waist-Hip Ratio

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review